Table 2 The statistics of non-synonymous somatic mutations in the pan-cancer driver (pcDriver) genes.

From: Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate

Cancer

White

Black

Asian

P-value

Q1

Q2

Q3

Q1

Q2

Q3

Q1

Q2

Q3

White::Black

White::Asian

Black::Asian

BLCA

7

11

16

5

8

13

3.5

7

11

1.9E-01

5.0E-03

4.7E-01

GBM

2

4

5

3

4

6

2

4

7

2.0E-01

7.2E-01

9.7E-01

HNSC

4

7

11

4.75

8.5

11

3.5

6

13

5.6E-01

7.7E-01

7.2E-01

KIRC

2

3

5

1.25

3.5

4

1

2

2

3.0E-01

1.5E-02

2.9E-01

LUAD

5

9

15

10

13

18

5.75

9.5

18.25

6.8E-03

6.2E-01

4.6E-01

LUSC

6

10

14

6

10

14

4

5

10

1.0E+00

1.4E-01

1.6E-01

BRCA

1

3

4

1

3

4

2

3

5

7.9E-01

1.4E-01

1.4E-01

OV

1

2

3

2

3

3

1

2.5

4.25

2.4E-01

5.8E-01

8.9E-01

UCEC

5

8

15

4

5

12

5

7

60

2.4E-02

3.4E-01

1.7E-02

COAD

5

7

12

5.5

7

15.5

5

10

73

9.3E-01

3.5E-01

4.7E-01

THCA

1

1

2

1

1

2

1

1

1

6.7E-01

6.3E-01

5.6E-01

CESC

2

3

7

2

3.5

6.25

1

2

4.5

9.3E-01

8.1E-02

2.0E-01

ESCA

3

5

7

6.25

6.5

6.75

3

5

6

2.7E-01

8.4E-01

2.0E-01

KIRP

1

2

4

1

1

2.5

0.75

1.5

2.25

2.7E-02

5.0E-01

8.2E-01

LIHC

2

3.5

5

3

4

6.5

2

3

6

2.0E-01

7.9E-01

3.2E-01

STAD

3

6

10.5

4

19.5

36.25

2

4

11

3.0E-01

4.0E-01

2.2E-01

  1. Q1, Q2 and Q3 are the first quantile, the second quantile (median) and the third quantile of mutation numbers, respectively. The number of tumor samples in each cancer-race group is the same as that in Table 1. P-values are calculated by the Mann Whitney test.